Effects of short- and long-term haloperidol administration and withdrawal on regional brain cholecystokinin and neurotensin concentrations in the rat

This publication has 31 references indexed in Scilit:

• Evidence for Cholecystokinin‐Dopamine Receptor Interactions in the Central Nervous System of the Adult and Old Rat
  Annals of the New York Academy of Sciences, 1985
• The effects of chronic neuroleptic treatment on neurotensin-like immunoreactivity in the rat central nervous system
  Brain Research, 1985
• Failure of chronic haloperidol treatment to alter levels of cholecystokinin in the rat brain striatum and olfactory tubercle-nucleus accumbens area
  Neuropeptides, 1984
• Cholecystokinin octapeptide levels in rat brain are changed after subchronic neuroleptic treatment
  European Journal of Pharmacology, 1983
• Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesions
  Life Sciences, 1983
• The origin of cholecystokinin terminals in the basal forebrain of the rat: Evidence from immunofluorencence and retrograde tracing
  Neuroscience Letters, 1983
• The Regional Distribution and Chromatographic Characterisation of Neurotensin‐Like Immunoreactivity in the Rat Central Nervous System
  Journal of Neurochemistry, 1982
• The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay
  Brain Research, 1981
• Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection
  European Journal of Pharmacology, 1980
• Immunochemical evidence of cholecystokinin-like peptides in brain
  Nature, 1976